UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 75

Sortiert nach

Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL

Leukemia, 2011-09, Vol.25 (9), p.1459-1466

2011

Link zum Volltext

Verfügbarkeit prüfen

Trisomy 12 CLLs progress through NOTCH1 mutations

Leukemia, 2013-03, Vol.27 (3), p.740-743

2013

Link zum Volltext

Verfügbarkeit prüfen

Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors

The Journal of clinical investigation, 1998-10, Vol.102 (8), p.1515-1525

1998

Link zum Volltext

Verfügbarkeit prüfen

Cirmtuzumab inhibits Wnt5a-induced Rac1 activation in chronic lymphocytic leukemia treated with ibrutinib

Leukemia, 2017-06, Vol.31 (6), p.1333-1339

2017

Link zum Volltext

Verfügbarkeit prüfen

Wnt5a induces ROR1 to associate with 14-3-3ζ for enhanced chemotaxis and proliferation of chronic lymphocytic leukemia cells

Leukemia, 2017-12, Vol.31 (12), p.2608-2614

2017

Link zum Volltext

Verfügbarkeit prüfen

Relative seroprevalence of human herpes viruses in patients with chronic lymphocytic leukaemia

European journal of clinical investigation, 2009-06, Vol.39 (6), p.497-506

2009

Link zum Volltext

Verfügbarkeit prüfen

ZAP-70 Compared with Immunoglobulin Heavy-Chain Gene Mutation Status as a Predictor of Disease Progression in Chronic Lymphocytic Leukemia

The New England journal of medicine, 2004-08, Vol.351 (9), p.893-901

2004

Link zum Volltext

Verfügbarkeit prüfen

Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia

Leukemia, 2017-06, Vol.31 (6), p.1348-1354

2017

Link zum Volltext

Verfügbarkeit prüfen

Lack of allelic exclusion in B cell chronic lymphocytic leukemia

The Journal of experimental medicine, 1997-04, Vol.185 (8), p.1435-1445

1997

Link zum Volltext

Verfügbarkeit prüfen

Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia

Leukemia, 2015-01, Vol.29 (1), p.86-95

2015

Link zum Volltext

Verfügbarkeit prüfen

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia

The Journal of experimental medicine, 2001-12, Vol.194 (11), p.1639-1647

2001

Link zum Volltext

Verfügbarkeit prüfen

The CLLU1 expression level is a stable and inherent feature of the chronic lymphocytic leukemia clone

Leukemia, 2009-06, Vol.23 (6), p.1182-1186

2009

Link zum Volltext

Verfügbarkeit prüfen

Subclonal evolution involving SF3B1 mutations in chronic lymphocytic leukemia

Leukemia, 2013-05, Vol.27 (5), p.1214-1217

2013

Link zum Volltext

Verfügbarkeit prüfen

CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia

Blood, 2000-11, Vol.96 (9), p.2917-2924

2000

Link zum Volltext

Verfügbarkeit prüfen

Genetic and epigenetic profiling of CLL disease progression reveals limited somatic evolution and suggests a relationship to memory-cell development

Blood cancer journal (New York), 2015-04, Vol.5 (4), p.e303-e303

2015

Link zum Volltext

Verfügbarkeit prüfen

The soluble CD40 ligand sCD154 in systemic lupus erythematosus

The Journal of clinical investigation, 1999-10, Vol.104 (7), p.947-955

1999

Link zum Volltext

Verfügbarkeit prüfen

Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B

Haematologica (Roma), 2015-07, Vol.100 (7), p.945

2015

Link zum Volltext

Verfügbarkeit prüfen

Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features

The Journal of immunology (1950), 1997-01, Vol.158 (1), p.235

1997

Link zum Volltext

Verfügbarkeit prüfen

An anti‐B cell autoantibody from Wiskott‐Aldrich syndrome which recognizes i blood group specificity on normal human B cells

European journal of immunology, 1992-07, Vol.22 (7), p.1781-1788

1992

Link zum Volltext

Verfügbarkeit prüfen

CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia

Blood, 2000-11, Vol.96 (9), p.2917-2924

2000

Link zum Volltext

Verfügbarkeit prüfen

Wnt5a induces ROR1 to associate with 14-3-3[zeta] for enhanced chemotaxis and proliferation of chronic lymphocytic leukemia cells

Leukemia, 2017-12, Vol.31 (12), p.2608

2017

Link zum Volltext

Verfügbarkeit prüfen

Autoantigen inhibits apoptosis of a human B cell leukemia that produces pathogenic rheumatoid factor

The Journal of immunology (1950), 1993-12, Vol.151 (12), p.7273

1993

Link zum Volltext

Verfügbarkeit prüfen

Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins

Blood, 2004-10, Vol.104 (8), p.2499-2504

2004

Link zum Volltext

Verfügbarkeit prüfen

Lack of extensive mutations in the VH5 genes used in common B cell chronic lymphocytic leukemia

The Journal of experimental medicine, 1993-04, Vol.177 (4), p.1039-1046

1993

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(74)
Buchkapitel
(1)

Sprache

Englisch
(75)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(49)
Humans
(48)
Life Sciences & Biomedicine
(48)
Leukemia, Lymphocytic, Chronic, B-Cell - Genetics
(31)
Hematology
(28)
Oncology
(20)
Biological And Medical Sciences
(18)
Medical Sciences
(17)
Adult
(16)
Female
(16)
Male
(16)
Leukemia, Lymphocytic, Chronic, B-Cell - Immunology
(15)
Hematologic And Hematopoietic Diseases
(14)
Molecular Sequence Data
(14)
Mutation
(14)
Aged
(13)
Chronic Lymphocytic Leukemia
(13)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(13)
Middle Aged
(13)
Leukemia
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL

Trisomy 12 CLLs progress through NOTCH1 mutations

Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors

Cirmtuzumab inhibits Wnt5a-induced Rac1 activation in chronic lymphocytic leukemia treated with ibrutinib

Wnt5a induces ROR1 to associate with 14-3-3ζ for enhanced chemotaxis and proliferation of chronic lymphocytic leukemia cells

Relative seroprevalence of human herpes viruses in patients with chronic lymphocytic leukaemia

ZAP-70 Compared with Immunoglobulin Heavy-Chain Gene Mutation Status as a Predictor of Disease Progression in Chronic Lymphocytic Leukemia

Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia

Lack of allelic exclusion in B cell chronic lymphocytic leukemia

Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia

The CLLU1 expression level is a stable and inherent feature of the chronic lymphocytic leukemia clone

Subclonal evolution involving SF3B1 mutations in chronic lymphocytic leukemia

CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia

Genetic and epigenetic profiling of CLL disease progression reveals limited somatic evolution and suggests a relationship to memory-cell development

The soluble CD40 ligand sCD154 in systemic lupus erythematosus

Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B

Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features

An anti‐B cell autoantibody from Wiskott‐Aldrich syndrome which recognizes i blood group specificity on normal human B cells

CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia

Wnt5a induces ROR1 to associate with 14-3-3[zeta] for enhanced chemotaxis and proliferation of chronic lymphocytic leukemia cells

Autoantigen inhibits apoptosis of a human B cell leukemia that produces pathogenic rheumatoid factor

Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins

Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic Leukemia

Lack of extensive mutations in the VH5 genes used in common B cell chronic lymphocytic leukemia

Suchergebnisse filtern